Innovative Approaches in Opioid Development: Ensysce Biosciences and the $14 Million Grant for PF614-MPAR.
Bioscience Company Secures $14 Million Grant For Clinical Development of Opioid Treatment
Bioscience Company Secures $14 Million Grant…
Bioscience Company Secures $14 Million Grant For Clinical Development of Opioid Treatment
Innovative Approaches in Opioid Development: Ensysce Biosciences and the $14 Million Grant for PF614-MPAR.